GBLTF yields 19230.77% · PFE yields 6.13%● Live data
📍 GBLTF pulled ahead of the other in Year 1
Combined, GBLTF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GBLTF + PFE for your $10,000?
GBLT Corp., through its subsidiary, German Battery Trading GmbH, manufactures and distributes mobile power products in Germany, the rest of the European Union, and internationally. It offers mobile lithium-based storage systems and solar panels, as well as a licenses home market for household storage systems under the Kodak brand; digital displays; LED lighting products under the Avide/ENTAC brand name; and face masks, disinfectants, insect repellants, and protective gloves, as well as electronic personal protection equipment products, such as fever thermometer, blood pressure oximeter, etc. under the Dr. Senst brand name. The company also produces and sells various types of batteries, such as lithium, alkaline, and heavy-duty batteries; and mobile energy products, such as batteries, storage systems, rechargeable batteries, and chargers under the AgfaPhoto brand name. In addition, it offers LED tubes and battery chemical systems; and medical products comprising hearing aid batteries and latex gloves under private labels. The company serves retail and commercial customers, as well as governments, public services, and industrial customers. It sells its products through supermarkets, department stores, drugstores, convenience stores, petrol stations, etc. The company is based in Toronto, Canada. GBLT Corp. is a subsidiary of SWT Beteiligungs AG.
Full GBLTF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.